65 related articles for article (PubMed ID: 10950800)
21. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy and safety of pristinamycin vs amoxicillin in community acquired pneumonia in adults].
Trémolières F; Mayaud C; Mouton Y; Weber P; Dellatolas F; Caulin E
Pathol Biol (Paris); 2005; 53(8-9):503-10. PubMed ID: 16181747
[TBL] [Abstract][Full Text] [Related]
23. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma.
Stiff P; Gingrich R; Luger S; Wyres MR; Brown RA; LeMaistre CF; Perry J; Schenkein DP; List A; Mason JR; Bensinger W; Wheeler C; Freter C; Parker WRL ; Emmanouilides C
Bone Marrow Transplant; 2000 Sep; 26(5):471-81. PubMed ID: 11019835
[TBL] [Abstract][Full Text] [Related]
24. Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial.
Schneider SB; Nishimura RD; Zimmerman RP; Tran L; Shiplacoff J; Tormey M; Contreras R; Juillard GF
Cytokines Cell Mol Ther; 1999 Sep; 5(3):175-80. PubMed ID: 10641576
[TBL] [Abstract][Full Text] [Related]
25. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
27. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
28. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
30. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease.
Korzenik JR; Dieckgraefe BK
Aliment Pharmacol Ther; 2005 Feb; 21(4):391-400. PubMed ID: 15709989
[TBL] [Abstract][Full Text] [Related]
31. Addition of macrolide in treating adult hospitalized community-acquired pneumonia.
Loh LC; Quah SY; Khoo SK; Vijayasingham P; Thayaparan T
Respirology; 2005 Jun; 10(3):371-7. PubMed ID: 15955152
[TBL] [Abstract][Full Text] [Related]
32. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
33. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group.
Heard SO; Fink MP; Gamelli RL; Solomkin JS; Joshi M; Trask AL; Fabian TC; Hudson LD; Gerold KB; Logan ED
Crit Care Med; 1998 Apr; 26(4):748-54. PubMed ID: 9559614
[TBL] [Abstract][Full Text] [Related]
34. Prevention of bacterial infections in patients with advanced HIV infection.
Mitsuyasu R
AIDS; 1999; 13 Suppl 2():S19-23. PubMed ID: 10596677
[TBL] [Abstract][Full Text] [Related]
35. Filgrastim in patients with pneumonia and severe sepsis or septic shock.
Wunderink R; Leeper K; Schein R; Nelson S; DeBoisblanc B; Fotheringham N; Logan E
Chest; 2001 Feb; 119(2):523-9. PubMed ID: 11171733
[TBL] [Abstract][Full Text] [Related]
36. [The use of Neupogen in prevention of purulent septic complications after radical surgery for esophageal cancer].
Drukin EIa; Manikhas GM; Pavlysh AV
Vopr Onkol; 1999; 45(6):660-2. PubMed ID: 10703517
[TBL] [Abstract][Full Text] [Related]
37. Filgrastim Labeling Confusion Leading to 10-Fold Overdose: What Is an MU?
Lee AC
Ann Pharmacother; 2018 Oct; 52(10):1053. PubMed ID: 29806468
[No Abstract] [Full Text] [Related]
38. Stem Cell-Based Therapy: A Promising Treatment for Diabetic Foot Ulcer.
El Hage R; Knippschild U; Arnold T; Hinterseher I
Biomedicines; 2022 Jun; 10(7):. PubMed ID: 35884812
[TBL] [Abstract][Full Text] [Related]
39. In canine bacterial pneumonia circulating granulocyte counts determine outcome from donor cells.
Applefeld WN; Wang J; Sun J; Pockros BM; Solomon SB; Feng J; Risoleo T; Cortés-Puch I; Gouél-Cheron A; Klein HG; Natanson C
Transfusion; 2020 Apr; 60(4):698-712. PubMed ID: 32086946
[TBL] [Abstract][Full Text] [Related]
40. Is There a Role for Hematopoietic Growth Factors During Sepsis?
Chousterman BG; Arnaud M
Front Immunol; 2018; 9():1015. PubMed ID: 29977234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
